KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioNTech SE (BNTX) Raw Materials (2018 - 2021)

Historic Raw Materials for BioNTech SE (BNTX) over the last 4 years, with Q4 2021 value amounting to $284.0 million.

  • BioNTech SE's Raw Materials rose 43778.19% to $284.0 million in Q4 2021 from the same period last year, while for Dec 2021 it was $284.0 million, marking a year-over-year increase of 43778.19%. This contributed to the annual value of $284.0 million for FY2021, which is 43778.19% up from last year.
  • According to the latest figures from Q4 2021, BioNTech SE's Raw Materials is $284.0 million, which was up 43778.19% from $203.9 million recorded in Q2 2021.
  • In the past 5 years, BioNTech SE's Raw Materials registered a high of $284.0 million during Q4 2021, and its lowest value of $5.1 million during Q4 2018.
  • Its 4-year average for Raw Materials is $111.0 million, with a median of $52.8 million in 2020.
  • As far as peak fluctuations go, BioNTech SE's Raw Materials surged by 7772.18% in 2019, and later skyrocketed by 48185.56% in 2020.
  • Over the past 4 years, BioNTech SE's Raw Materials (Quarter) stood at $5.1 million in 2018, then surged by 77.72% to $9.1 million in 2019, then skyrocketed by 481.86% to $52.8 million in 2020, then skyrocketed by 437.78% to $284.0 million in 2021.
  • Its last three reported values are $284.0 million in Q4 2021, $203.9 million for Q2 2021, and $52.8 million during Q4 2020.